Key result
A tricuspid regurgitant fraction cutoff of 21.6% by cardiac MRI was identified as an independent predictor of deterioration in systemic right ventricular ejection fraction over time.
Why the study?
Does quantitative assessment of tricuspid regurgitant fraction predict deterioration in systemic right ventricular ejection fraction in adults with a systemic right ventricle?
Does quantitative assessment of tricuspid regurgitant fraction predict deterioration in systemic right ventricular ejection fraction in adults with a systemic right ventricle?
Quantitative assessment of tricuspid regurgitation by CMR provides an objective marker to predict functional deterioration of the systemic right ventricle in adults with congenital heart disease.
The field of adult congenital heart disease (ACHD) has continued to expand over the last few decades, with adults now outnumbering children living with congenital heart disease (CHD).1,2 Although many of these patients have undergone surgical intervention which result in a relatively “normal” circulation, a large percentage are left with persistent anatomic and physiologic abnormalities when compared with the general population. Prime examples are those with a systemic right ventricle (sRV), such as patients with d-transposition of the great arteries (D-TGA) who have undergone an atrial switch operation or those with congenitally corrected transposition (ccTGA).
No takes yet. Share an insight, caveat, or question.
McEachern et al. (2024) conducted an editorial in Congenital heart disease with a systemic right ventricle (ccTGA or D-TGA) (n=17). Tricuspid regurgitation fraction (TRF) ≥21.6% was evaluated on Decline in systemic right ventricular ejection fraction (sRVEF). A tricuspid regurgitant fraction cutoff of 21.6% by cardiac MRI was identified as an independent predictor of deterioration in systemic right ventricular ejection fraction over time.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: